News | September 10, 2008

Preclinical Imaging Seen from ‘New Point of View’

September 11, 2008 - For the fifth year, Siemens Healthcare (www.siemens.com/healthcare) presented the “New Point of View” Preclinical Image of the Year Awards, designed to demonstrate how Siemens preclinical imaging systems help researchers improve the quality of imaging and overall research, at the Siemens Preclinical User’s Group Meeting, held in Nice, France.

The awards are intended to honor pioneering researchers and their contributions. Advanced new imaging solutions and multimodal systems are shedding new light on dissecting disease processes and unlocking potential new treatments. Images were acquired on Siemens preclinical imaging systems: the Inveon preclinical scanner and the microPET (positron emission tomography) and microCAT (computed axial tomography) scanners, which have been long-time industry leaders.

“The ‘New Point of View’ image competition illustrates the breadth and novelty of applications for which preclinical imaging technologies are being used. The potential for breakthrough discoveries will eventually have impact in the clinical environment through translational research,” said Kirti Patel, vice president, Preclinical Solutions, Siemens Healthcare. “Our focus is to provide high-quality preclinical imaging tools and workflow solutions that will speed the discovery process for our customers.”

The “New Point of View” competition was open to anyone with a Siemens preclinical scanner. Researchers were allowed to use any type of radiopharmaceutical tracer or any other contrast material. Entries were judged on scientific merit, the type of information gleaned from the images and the overall quality of the images. All images were judged by a panel of industry experts and members of Siemens Preclinical Research and Development team.

Inveon Image of the Year Winner
“4-Dimensional Dosimetry of 131I-NM404 Using µPET/CT and Pinnacle,” acquired by J. Grudzinski, M. Christensen, W. Tome, M. Bahl and J. Weichert, University of Wisconsin.

Multimodality Image of the Year Winner
“Quantification of PECAM-1 Expression in Regions of Myocardial Infarction Using MR-PET,” acquired by L. Locke, Z. Yang, Y. Zhang, R. Tian, B. Kundu, J. Linden, S. Berr and D. Pan, University of Virginia.

Most Innovative Image of the Year Winner
“Kit-like” labeling of PET tracers: 18F-SiFA for bloodpool imaging of transplanted rat hearts,” acquired by G. Boening, University of Munich.

Drug Discovery Image of the Year Winner
“P-glycoprotein modulation at the rat blood-brain barrier studied with (R)-[11C]-Verapamil PET,” acquired by C. Kuntner, J. Bankstahl, A. Abrahim, R. Karch, J. Stanek, T. Wanek, M. Zsebedics, W. Wadsak, K. Kletter, M. Müller, W. Löscher, O. Langer, Austrian Research Centers GmbH-ARC.

For more information: www.usa.siemens.com/healthcare

Related Content

PET/CT Changes Care for 59 Percent of Suspected Recurrent Prostate Cancer Cases
News | Prostate Cancer | June 13, 2018
A recently presented investigational clinical trial evaluated the impact of 18F fluciclovine positron emission...
News | Computed Tomography (CT) | May 21, 2018
The Istituto Oncologico Veneto (IOV) in Padua, Italy, has acquired MILabs’ latest-generation Versatile Emission...
PET Imaging Agent Could Provide Early Diagnosis of Rheumatoid Arthritis

Coronal 18F-FEDAC PET/CT section of a mouse with collagen-induced arthritis. (A) On day 23 and day 37, increased uptake is noted in the front and hind paws of this mouse with collagen-induced arthritis. (B) Predictive performance of day 23 18F-FEDAC uptake for the development of clinical arthritis. ROC = receiver operating characteristic; Sn = sensitivity; Sp = specificity. Credit: Seoul National University and Ewha Womans University, Seoul, South Korea

News | PET Imaging | May 17, 2018
A novel positron emission tomography (PET) tracer developed by Korean researchers can visualize joint inflammation and...
PET Imaging Shows Protein Clumping May Contribute to Heart Failure Development
News | PET Imaging | May 11, 2018
A team led by Johns Hopkins University Researchers has discovered that protein clumps appear to accumulate in the...
News | Radiopharmaceuticals and Tracers | May 09, 2018
Blue Earth Diagnostics signed an exclusive, worldwide agreement with Scintomics GmbH, Germany, a specialist in...
Novel PET Agent Could Help Guide Therapy for Brain Diseases

Rat brain 11C‐Me‐NB1 PET images (0‐60 min) superimposed on an MRI template. Credit: SD Krämer et al., ETH Zurich, Zurich, Switzerland

News | PET Imaging | April 10, 2018
Researchers have developed a new imaging agent that could help guide and assess treatments for people with various...
Imaging agent helps predict success of lung cancer therapy
News | Oncology Diagnostics | March 08, 2018
March 8, 2018 – Doctors contemplating the best therapy for...
Axumin PET Agent Added to NCCN Guidelines for Suspected Recurrent Prostate Cancer
News | PET Imaging | February 21, 2018
Blue Earth Diagnostics announced that Axumin (fluciclovine F 18) injection has been added to the National Comprehensive...
PSMA PET-CT Clearly Differentiates Prostate Cancer from Benign Tissue

68Ga-PSMA PET/CT images showing multifocal PCA in peripheral zone with GS of 5 1 5 5 10. (A and C) Axial PET images. (B and D) Fused PET/CT images. SUVmax of lesion in B was 84.3 and that of lesion in D was 5.7. IRS was 3, and 80% of cells were stained. Credit: Senior author V Prasad, Charité Universitätsmedizin Berlin, Berlin, Germany.

News | PET-CT | February 05, 2018
February 5, 2018 — Using nuclear medicine...
PET Tracer Measures Damage From Multiple Sclerosis in Mouse Models
News | PET Imaging | January 24, 2018
January 24, 2018 — The loss or damage of myelin, a cellular sheath that surrounds and insulates nerves, is the hallma
Overlay Init